array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "Gsk Consumer Health, Inc."
["slug"]=>
string(32) "4abba-us-gsk-consumer-health-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204"
["description"]=>
string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company."
["address_street"]=>
string(28) "184 Liberty Corner Rd Ste 78"
["address_place"]=>
string(6) "Warren"
["address_region"]=>
string(10) "New Jersey"
["founding_date"]=>
string(10) "1994-02-28"
["website_domain"]=>
string(7) "gsk.com"
["website_url"]=>
string(19) "https://www.gsk.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(300)
["article_count"]=>
int(461)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(47) "Haleon Pretax Profit Rises Despite Revenue Drop"
["snippet_en"]=>
string(15) "By Najat Cantor"
["url"]=>
string(103) "https://www.morningstar.com/news/dow-jones/202405011046/haleon-pretax-profit-rises-despite-revenue-drop"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/17ad0cb6-615b-41ee-95d4-b14177d467e9"
["source"]=>
string(15) "morningstar.com"
["publication_date"]=>
string(10) "2024-05-01"
["categories"]=>
array(1) {
[0]=>
string(31) "Financial Update/Profit Warning"
}
}
[1]=>
array(7) {
["title_en"]=>
string(62) "Mutual Advisors LLC Purchases 452 Shares of GSK plc (NYSE:GSK)"
["snippet_en"]=>
string(219) "Mutual Advisors LLC boosted its position in shares of GSK plc (NYSE:GSK – Free Report) by 4.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission."
["url"]=>
string(104) "https://www.defenseworld.net/2024/03/29/mutual-advisors-llc-purchases-452-shares-of-gsk-plc-nysegsk.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5e6582b5-a950-4b28-8346-d30754db91b5"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2024-03-29"
["categories"]=>
array(6) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(12) "Stock Market"
[2]=>
string(31) "Financial Update/Profit Warning"
[3]=>
string(11) "Regulations"
[4]=>
string(18) "General Investment"
[5]=>
string(15) "Market Movement"
}
}
[2]=>
array(7) {
["title_en"]=>
string(79) "SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update"
["snippet_en"]=>
string(51) "SCY-247’s IND-enabling activities continue to adv"
["url"]=>
string(109) "https://forextv.com/top-news/scynexis-reports-full-year-2023-financial-results-and-provides-corporate-update/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/21671bac-95f3-43d7-abfb-fd6a0cbfbde3"
["source"]=>
string(11) "forextv.com"
["publication_date"]=>
string(10) "2024-03-29"
["categories"]=>
array(1) {
[0]=>
string(31) "Financial Update/Profit Warning"
}
}
[3]=>
array(7) {
["title_en"]=>
string(79) "FTSE 100 Live: Blue chips higher, Currys ups guidance, Pfizer sells down Haleon"
["snippet_en"]=>
string(150) "FTSE 100 9 points higher at 7,736 Currys ups profit guidance Pfizer sells down Haleon stake 9:57am: World's largest solar panel manufacturer to cut..."
["url"]=>
string(145) "https://proactiveinvestors.co.uk/companies/news/1043333/ftse-100-live-blue-chips-higher-currys-ups-guidance-pfizer-sells-down-haleon-1043333.html"
["image_url"]=>
NULL
["source"]=>
string(24) "proactiveinvestors.co.uk"
["publication_date"]=>
string(10) "2024-03-18"
["categories"]=>
array(7) {
[0]=>
string(11) "Acquisition"
[1]=>
string(12) "Stock Market"
[2]=>
string(31) "Financial Update/Profit Warning"
[3]=>
string(19) "Green & Responsible"
[4]=>
string(8) "Downtime"
[5]=>
string(18) "General Investment"
[6]=>
string(13) "Collaboration"
}
}
[4]=>
array(7) {
["title_en"]=>
string(38) "GSK Require Regulatory Project Manager"
["snippet_en"]=>
string(305) "GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive."
["url"]=>
string(85) "https://www.pharmatutor.org/content/march-2024/Gsk-require-regulatory-project-manager"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0372459a-5c4c-4f9a-a9e2-ec4a40c24944"
["source"]=>
string(15) "pharmatutor.org"
["publication_date"]=>
string(10) "2024-03-13"
["categories"]=>
array(1) {
[0]=>
string(31) "Financial Update/Profit Warning"
}
}
[5]=>
array(7) {
["title_en"]=>
string(53) "GSK plc (NYSE:GSK) Shares Sold by Sei Investments Co."
["snippet_en"]=>
string(300) "Sei Investments Co. decreased its position in GSK plc (NYSE:GSK - Free Report) by 28.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 633,530 shares of the pharmaceutical company's stock after se"
["url"]=>
string(73) "https://www.marketbeat.com/instant-alerts/nyse-gsk-sec-filing-2024-03-10/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c1d46a40-ff0b-419f-ba04-8b09ad6e7c00"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2024-03-10"
["categories"]=>
array(5) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(12) "Stock Market"
[2]=>
string(31) "Financial Update/Profit Warning"
[3]=>
string(11) "Regulations"
[4]=>
string(18) "General Investment"
}
}
[6]=>
array(7) {
["title_en"]=>
string(81) "GSK rewards CEO Emma Walmsley with 51% pay hike after beating sales, profit goals"
["snippet_en"]=>
string(299) "With the fortunes of GSK on the rise after much tumult early in the decade, the company has rewarded CEO Emma Walmsley with a significant pay boost. | With the fortunes of GSK on the rise after much tumult early in the decade, the company has rewarded CEO Emma Walmsley with a significant pay boost."
["url"]=>
string(94) "https://www.fiercepharma.com/pharma/gsk-rewards-ceo-walmsley-51-pay-hike-after-successful-2023"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4eb1536c-2089-4725-8f5d-ebcd5ab96601"
["source"]=>
string(16) "fiercepharma.com"
["publication_date"]=>
string(10) "2024-03-05"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(12) "Board Change"
}
}
[7]=>
array(7) {
["title_en"]=>
string(72) "GSK earns 5,767 million euros in 2023, 67.1% less than the previous year"
["snippet_en"]=>
string(139) "The British pharmaceutical company's profits in the fourth quarter were 409.6 million euros, 76.6% less than in the same period of 2023...."
["url"]=>
string(109) "https://www.plantadoce.com/empresa/gsk-gana-5767-millones-de-euros-en-2023-un-671-menos-que-el-ano-precedente"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4f0474f8-b14c-4fa4-bfed-d79cc713875f"
["source"]=>
string(14) "plantadoce.com"
["publication_date"]=>
string(10) "2024-01-31"
["categories"]=>
array(3) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(18) "Financial Distress"
[2]=>
string(24) "Quarterly/Annual Figures"
}
}
[8]=>
array(7) {
["title_en"]=>
string(88) "Pharmaceutical manufacturer GSK is raising targets again - RSV vaccination is going well"
["snippet_en"]=>
string(277) "The pharmaceutical company GSK continued its good run with another surprisingly strong quarter. The management around company boss Emma Walmsley is now raising the bar for the year for a second time after the British suffered declining revenues in the third quarter of the year"
["url"]=>
string(97) "https://www.cash.ch/news/pharmahersteller-gsk-hebt-erneut-ziele-an-rsv-impfung-lauft-stark-652332"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f519334f-2306-475d-b9a8-ed12981f0dd0"
["source"]=>
string(7) "cash.ch"
["publication_date"]=>
string(10) "2023-11-01"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(30)
}
[1]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(27)
}
[2]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(27)
}
[3]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(23)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(20)
}
[5]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(18)
}
[6]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(17)
}
[7]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(17)
}
[8]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(17)
}
[9]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(14)
}
[10]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(14)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(13)
}
[12]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[15]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(10)
}
[16]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(6) "Crisis"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(8)
}
[20]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(6)
}
[23]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(21) "Cultural developments"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(6)
}
[27]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(6)
}
[29]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(6)
}
}
}
4abba-us-gsk-consumer-health-inc
Gsk Consumer Health, Inc.
Location
New Jersey
Founded
1994-02-28
Website
https://www.gsk.com
Articles
461 Articles
Category
Pharmaceutical Preparations
Description
GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company.
Mutual Advisors LLC boosted its position in shares of GSK plc (NYSE:GSK – Free Report) by 4.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive.
Sei Investments Co. decreased its position in GSK plc (NYSE:GSK - Free Report) by 28.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 633,530 shares of the pharmaceutical company's stock after se
With the fortunes of GSK on the rise after much tumult early in the decade, the company has rewarded CEO Emma Walmsley with a significant pay boost. | With the fortunes of GSK on the rise after much tumult early in the decade, the company has rewarded CEO Emma Walmsley with a significant pay boost.
The pharmaceutical company GSK continued its good run with another surprisingly strong quarter. The management around company boss Emma Walmsley is now raising the bar for the year for a second time after the British suffered declining revenues in the third quarter of the year
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
